GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » Deferred Tax

BioPharma Credit (LSE:BPCR) Deferred Tax : $0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

BioPharma Credit's change in deferred tax for the six months ended in Dec. 2024 was $0.0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2024 was $0.0 Mil.

BioPharma Credit Deferred Tax Historical Data

The historical data trend for BioPharma Credit's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPharma Credit Deferred Tax Chart

BioPharma Credit Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Deferred Tax
Get a 7-Day Free Trial - - - - -

BioPharma Credit Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BioPharma Credit Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioPharma Credit Deferred Tax Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

BioPharma Credit Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » Deferred Tax
Comparable Companies
LSE:ESCT LSE:IEM LSE:ICGT LSE:SDP LSE:MNTN LSE:GSCT LSE:NBPE LSE:CORD LSE:OCI LSE:IAD BLK BX KKR OSTO:INVE A TSX:BAM TSX:BN APO LSE:III AMP XSWX:PGHN
Traded in Other Exchanges
N/A
Address
29 Wellington Street, Central Square, Leeds, GBR, LS1 4DL
Website
https://www.bpcruk.com
BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit Headlines

No Headlines